Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dopamine Interactions
2001
Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors
1997
Recognition of multiple partial discharge patterns by multi‐class support vector machine using fractal image processing technique
2018 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
“Selective” serotonin 5-HT2A receptor antagonists
2022
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress
2005
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
2008
Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats
2005
Contribution of 5-HT2Receptor Subtypes to Sleep–Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2AReceptors
2005
Serotonin: from top to bottom
2012
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists
1997
Human Trabecular Meshwork Cells Express Functional Serotonin-2A (5HT2A) Receptors: Role in IOP Reduction
2006
Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and α1-adrenergic receptor
2009
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus
2000
Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone
2003
Functional study of rat 5‐HT2A receptors using antisense oligonucleotides
2003
Descending control of pain
2002 Standout
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Schizophrenia
2009 Standout
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat
1998
Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT 2C receptors in Wistar rats
2003
Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5‐HT2A and 5‐HT2C receptors
2002
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains
2001
Activation of 5-HT 2B Receptors in the Medial Amygdala causes Anxiolysis in the Social Interaction Test in the Rat
1997
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic Agent
2001
Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists
2005
Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain
2013
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
2007 Standout
5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex
1999
Psychedelics
2016 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors
2001
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Serotonergic Drugs
2007
SB‐272183, a selective 5‐HT1A, 5‐HT1B and 5‐HT1D receptor antagonist in native tissue
2001
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists
2003
RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms
2004
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
2017
Constitutive Activity of the Serotonin2C Receptor InhibitsIn VivoDopamine Release in the Rat Striatum and Nucleus Accumbens
2004
Acute Selective Serotonin Reuptake Inhibitors Increase Conditioned Fear Expression: Blockade With a 5-HT2C Receptor Antagonist
2007
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
2012 Standout
The 5-Hydroxytryptamine4 Receptor Exhibits Frequency-dependent Properties in Synaptic Plasticity and Behavioural Metaplasticity in the Hippocampal CA1 Region In vivo
2004
The Selective Serotonin2A Receptor Antagonist, MDL100,907, Elicits a Specific Interoceptive Cue in Rats
2002
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Stimulation of 5‐hydroxytryptamine (5‐HT2C) receptors in the ventrotegmental area inhibits stress‐induced but not basal dopamine release in the rat prefrontal cortex
2002
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
The Serotonin Syndrome
2005 Standout
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
2000
The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats
2000
The elevated T-maze as an experimental model of anxiety
1998
Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity, Role of 5-HT1B/1D and 5-HT2 Receptors
2002
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
2020 StandoutNobel
Modulation by Serotonin 5-HT4 Receptors of Long-term Potentiation and Depotentiation in the Dentate Gyrus of Freely Moving Rats
2002
Neurobiology of Depression
2002 Standout
Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens
1998
5‐HT 2C receptor modulation and the treatment of obesity
1999
RS‐127445: a selective, high affinity, orally bioavailable 5‐HT2B receptor antagonist
1999
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
The use of spirocyclic scaffolds in drug discovery
2014 Standout
A review of central 5-HT receptors and their function
1999 Standout
Major Depressive Disorder
2008 Standout
Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum
2000
The neural basis of psychedelic action
2022 Standout
Opposing Roles for 5-HT2A and 5-HT2C Receptors in the Nucleus Accumbens on Inhibitory Response Control in the 5-Choice Serial Reaction Time Task
2007
Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats
2007
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
2011 Standout
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Serotonin and Hallucinogens
1999
Climate change, environment pollution, COVID-19 pandemic and mental health
2021
Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice
2003
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion
2004
RS-102221: A Novel High Affinity and Selective, 5-HT 2C Receptor Antagonist
1997
Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice
2005
Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system
1997
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
BW 723C86, a 5-HT2B Receptor Agonist, Causes Hyperphagia and Reduced Grooming in Rats
1997
Serotonin Modulates Fast-Spiking Interneuron and Synchronous Activity in the Rat Prefrontal Cortex through 5-HT1Aand 5-HT2AReceptors
2010
Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
2007
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways
2003
Aversive stimulus properties of the 5-HT2C receptor agonist WAY 161503 in rats
2006
A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation
2002
Endogenous serotonin and serotonin2Creceptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade
2008
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis
1999
Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors
2005
Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
2003
Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats
2008
Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists
2001
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade
2004
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
1998
8-OH-DPAT-induced Spontaneous Tail-flicks in the Rat are Facilitated by the Selective Serotonin (5-HT) 2C Agonist, RO 60-0175: Blockade of its Actions by the Novel 5-HT 2C Receptor Antagonist SB 206,553
1997
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
2005 Standout
Serotonin and the 5-HT2BReceptor in the Development of Enteric Neurons
2000
Climate Change 2022 – Impacts, Adaptation and Vulnerability
2023 Standout
Serotonin in Affective Control
2009
Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
2003
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy
2001
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
Novel Cell-Based Hepatitis C Virus Infection Assay for Quantitative High-Throughput Screening of Anti-Hepatitis C Virus Compounds
2013
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
2000
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
2012
About Sleep's Role in Memory
2013 Standout
Emerging drugs for schizophrenia
2008
Modulation of dopamine release by striatal 5‐HT2C receptors
2005
DOI-Induced Activation of the Cortex: Dependence on 5-HT2AHeteroceptors on Thalamocortical Glutamatergic Neurons
2000
Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators
2011
Microglial M1/M2 polarization and metabolic states
2015 Standout
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
5-HT2AReceptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex
1997
Evidence That 5-HT2AReceptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (−)DOI
2002
5-HT2C Receptor Agonists: Pharmacological Characteristics and Therapeutic Potential
1998
Hallucinogens
2004 Standout
Works of Fiona Bright being referenced
Effects of RO 60 0175, a 5-HT2C receptor agonist, in three animal models of anxiety
2000
Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated
1998
Neuroinflammation in frontotemporal dementia
2019
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
1997
Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex
2017
In vitroandin vivoprofile of SB 206553, a potent 5‐HT2C/5‐HT2Breceptor antagonist with anxiolytic‐like properties
1996
Anxiolytic-like Actions of the Selective 5-HT 4 Receptor Antagonists SB 204070A and SB 207266A in Rats
1997
Effects of the 5‐HT2B receptor agonist, BW 723C86, on three rat models of anxiety
1996